CRISPR Therapeutics and Anagenesis Biotechnologies announce Strategic In-Licensing and Collaboration Agreement.
  • 8
    Jun

CRISPR Therapeutics and Anagenesis Biotechnologies announce Strategic In-Licensing and Collaboration Agreement.

  • Posted by:
  • Anagenesis

CRISPR Therapeutics and Anagenesis Biotechnologies announce Strategic In-Licensing and Collaboration Agreement to develop CRISPR/Cas9-Based Cell Therapies for Muscles Diseases.
Crispr_Anagenesis PR_6 8 16

CRISPR – Anagenesis CP_FR 8 06 16 F